Changes to the Code
S. 2846 · HIV Medication Access Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
22 U.S.C. § 2151b–2 Assistance to combat HIV/AIDS
9 changes the bill asks for here, 8 carried out
- Carried out:
in the matter preceding subparagraph (A), by inserting
, which shall be considered to be core life-saving humanitarian assistance,
beforeincluding
; - Carried out:
in subparagraph (J), by striking the period at the end and inserting a semicolon
;
- Carried out:
in subparagraph (K)(viii), by striking the period at the end and inserting
; and
; and - Carried out:
by adding at the end the following:
(L) assistance to provide HIV pre-exposure prophylaxis (PrEP) medications.;
- Not carried out:
subparagraph (D), by adding
and
at the end; andWe can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: subparagraph (X), by adding QTEXT at the end; and - Carried out:
in subparagraph (E), by striking the semicolon at the end and inserting a period
;
and - Carried out:
by inserting
, including at-risk populations in accordance with a scientific-based analysis designated by the World Health Organization,
afterspecific populations
; - Carried out:
by striking
efforts to reduce the risk of HIV/AIDS infection including
and insertingefforts to reduce the risk of HIV/AIDS infection, which shall be considered to be core life-saving humanitarian assistance, including pre- and
; and - Carried out:
by inserting
, which shall be considered to be core life-saving humanitarian assistance
before the period at the end.
§ 2151b–2(d)Activities supported(1)
Start of § 2151b–2 to (c)(3) unchanged ·
(d) Activities supported Assistance provided under subsection (c) shall, to the maximum extent practicable, be used to carry out the following activities:
(1) Prevention Prevention of HIV/AIDS through activities [inserted: , which shall be considered to be core life-saving humanitarian assistance, ]including—
(A) programs and efforts that are designed or intended to impart knowledge with the exclusive purpose of helping individuals avoid behaviors that place them at risk of HIV infection, including integration of such programs into health programs and the inclusion in counseling programs of information on methods of avoiding infection of HIV, including delaying sexual debut, abstinence, fidelity and monogamy, reduction of casual sexual partnering and multiple concurrent sexual partnering,,2 reducing sexual violence and coercion, including child marriage, widow inheritance, and polygamy, and where appropriate, use of male and female condoms;
(B) assistance to establish and implement culturally appropriate HIV/AIDS education and prevention programs that are designed with local input and focus on helping individuals avoid infection of HIV/AIDS, implemented through nongovernmental organizations, including faith-based and community-based organizations, particularly those locally based organizations that utilize both professionals and volunteers with appropriate skills, experience, and community presence;
§ 2151b–2(d)(1)Prevention(I)–(K)
(d)(1)(C)–(H) unchanged ·
(I) assistance to help avoid substance abuse and intravenous drug use that can lead to HIV infection;
(J) assistance for the purpose of increasing women’s access to employment opportunities, income, productive resources, and microfinance programs, where appropriate[struck: .][inserted: ;]
(K) assistance for counseling, testing, treatment, care, and support programs, including—
(i) counseling and other services for the prevention of reinfection of individuals with HIV/AIDS;
§ 2151b–2(d)Activities supported(1)–(2)
(d)(1)(K)(ii)–(vi) unchanged ·
(vii) strategies to address the stigma and discrimination that impede HIV/AIDS prevention efforts; and
(viii) assistance to facilitate widespread access to microbicides for HIV prevention, if safe and effective products become available, including financial and technical support for culturally appropriate introductory programs, procurement, distribution, logistics management, program delivery, acceptability studies, provider training, demand generation, and postintroduction monitoring[struck: .][inserted: ; and]
(L) [inserted: assistance to provide HIV pre-exposure prophylaxis (PrEP) medications.]
(2) Treatment The treatment and care of individuals with HIV/AIDS, including—
(A) assistance to establish and implement programs to strengthen and broaden indigenous health care delivery systems and the capacity of such systems to deliver HIV/AIDS pharmaceuticals and otherwise provide for the treatment of individuals with HIV/AIDS, including clinical training for indigenous organizations and health care providers;
§ 2151b–2(d)Activities supported(2)–(4)
(d)(2)(B)–(C) unchanged ·
(D) as part of care and treatment of HIV/AIDS, assistance (including prophylaxis and treatment) for common HIV/AIDS-related opportunistic infections for free or at a rate at which it is easily affordable to the individuals and populations being served;4
(E) as part of care and treatment of HIV/AIDS, assistance or referral to available and adequately resourced service providers for nutritional support, including counseling and where necessary the provision of commodities, for persons meeting malnourishment criteria and their families[struck: ;][inserted: .]
(3) Preventative intervention education and technologies
(A) With particular emphasis on specific populations[inserted: ,] [inserted: including at-risk populations in accordance with a scientific-based analysis designated by the World Health Organization, ]that represent a particularly high risk of contracting or spreading HIV/AIDS, including those exploited through the sex trade, victims of rape and sexual assault, individuals already infected with HIV/AIDS, and in cases of occupational exposure of health care workers, assistance with efforts to reduce the risk of HIV/AIDS infection[inserted: ,] [inserted: which shall be considered to be core life-saving humanitarian assistance, ]including [inserted: pre- and ]post-exposure pharmaceutical prophylaxis, and necessary pharmaceuticals and commodities, including test kits, condoms, and, when proven effective, microbicides[inserted: , which shall be considered to be core life-saving humanitarian assistance].
(B) Bulk purchases of available test kits, condoms, and, when proven effective, microbicides that are intended to reduce the risk of HIV/AIDS transmission and for appropriate program support for the introduction and distribution of these commodities, as well as education and training on the use of the technologies.
(4) Monitoring The monitoring of programs, projects, and activities carried out pursuant to paragraphs (1) through (3), including—
Rest of § 2151b–2 unchanged ·